Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The ALL Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The ALL Channel on VJHemOnc is supported by Jazz Pharmaceuticals. The supporter has no influence over the production of the content.

Welcome to The Acute Lymphoblastic Leukemia (ALL) Channel

Alongside a world-leading Editorial Board, VJHemOnc can provide all of the latest updates you need in ALL. Speaking directly with the experts at international congresses, The ALL Channel brings you video interviews, podcasts, roundtable discussions and more.

As well as therapy updates including CAR-T, antibody-drug conjugates and chemotherapy, The ALL Channel covers advances in transplantation, measurable residual disease (MRD), managing therapy toxicities, diagnosing ALL and more.


EBMT 2024
ESH AL 2024
CAR-T Meeting 2024
ASH 2023
SOHO 2023
EHA 2023


CAR-T & Cellular Therapy
Trial Updates